Biological therapy was associated with significant changes in lung structure and, by extension, improved lung function in individuals with chronic obstructive pulmonary disease ( COPD) and T2 ...

Sotatercept, an activin-signaling inhibitor, reduces morbidity and mortality among patients with long-standing pulmonary arterial hypertension. Its effects in patients with pulmonary arterial ...

The biologic dosed every 2 weeks reduced moderate or severe COPD exacerbations over 52 weeks by a relative 15.4% compared with placebo atop standard care (annualized rate 1.11 vs 1.31, P =0.049), ...

Daily use of inhaled cannabis linked to increased risks, with risk for asthma significantly increased even with no lifetime tobacco cigarette use ...

Research reveals strong connections between muscle strength and cognitive function in patients with COPD, highlighting the potential for rehabilitation strategies.

Experts at European Respiratory Society (ERS) Congress 2025 highlight the critical link between reduced lung function and increased cardiovascular disease risk, urging early intervention and awareness ...

Singing can improve the quality of life of people with lung disease and help reduce their symptoms, according to a gold-standard randomized-controlled trial presented at the European Respiratory ...

Singing can improve the quality of life of people with lung disease and help reduce their symptoms, according to a gold-standard randomzed-controlled trial presented at the Congress in Amsterdam, the ...

I’ve recently been reflecting on how Maslow’s hierarchy of needs intersects with chronic illness, moderate means, and the dignity of helping others. I’m doing so through the lens of my chronic ...